Blood Culture Contamination Clinical Trial
Official title:
A Randomized Controlled Study of Blood Test Draw Order to Reduce Blood Culture Contamination
Verified date | September 2018 |
Source | Shaare Zedek Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A randomized partially controlled study to examine the effect of blood diversion into a heparin lithium tube on the incidence of blood culture contamination.
Status | Completed |
Enrollment | 970 |
Est. completion date | February 28, 2019 |
Est. primary completion date | February 28, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age > 18 - Presence in Emergency Room during extended office hours (0800-2000 on weekdays( - Clinical requirement for Blood culture and biochemistry tests from venepuncture Exclusion Criteria: - None |
Country | Name | City | State |
---|---|---|---|
Israel | Shaare Zedek Medical Center | Jerusalem |
Lead Sponsor | Collaborator |
---|---|
Shaare Zedek Medical Center |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Blood culture contamination | Growth of bacteria defined as blood culture contaminants (for example coagulase negative staphylococci in one bottle only). | up to 7 days from obtaining blood culture | |
Secondary | Patient length of stay | Length of stay from arrival at Emergency room until discharge in hours | up to 3 months from arrival |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05576233 -
• Comparison of Blood Culture Contamination Rates
|
N/A | |
Completed |
NCT04573894 -
Diagnostic Performance of Plasma Procalcitonin for the Detection of Blood Cultures Contaminations
|